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Abstract
Background:  Collection of buccal cells from saliva for DNA extraction offers a less invasive and
convenient alternative to venipuncture blood collection that may increase participation in genetic
epidemiologic studies. However, dried blood spot collection, which is also a convenient method, offers a
means of collecting peripheral blood samples from which analytes in addition to DNA can be obtained.
Methods:  To determine if offering blood spot collection would increase participation in genetic
epidemiologic studies, we conducted a study of collecting dried blood spot cards by mail from a sample of
female cancer cases (n = 134) and controls (n = 256) who were previously selected for a breast cancer
genetics study and declined to provide a venipuncture blood sample. Participants were also randomized
to receive either a $2.00 bill or no incentive with the blood spot collection kits.
Results: The average time between the venipuncture sample refusal and recruitment for the blood spot
collection was 4.4 years. Thirty-seven percent of cases and 28% of controls provided a dried blood spot
card. While the incentive was not associated with participation among controls (29% for $2.00 incentive
vs. 26% for no incentive, p = 0.6), it was significantly associated with participation among the breast cancer
cases (48% vs. 27%, respectively, p = 0.01). There did not appear to be any bias in response since no
differences between cases and controls and incentive groups were observed when examining several
demographic, work history and radiation exposure variables.
Conclusion:  This study demonstrates that collection of dried blood spot cards in addition to
venipuncture blood samples may be a feasible method to increase participation in genetic case-control
studies.
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Background
Increasingly, large epidemiologic cohort and case-control
studies include collection of biologic specimens because
genetic and/or clinical information are key elements of
the hypotheses under study. Many studies have collected
buccal cells from saliva for DNA extraction; however,
blood samples are more versatile because in addition to
DNA, several analytes can be measured in the serum [1].
Venipuncture blood collection can be difficult to under-
take due to cost, organizational complexity, and shipping
and storage requirements. More importantly, subject
inconvenience (i.e. arranging an appointment with and
travelling to see a phlebotomist) and invasiveness of the
method can decrease participation. Alternatively, dried
blood spot collection of capillary blood via finger stick
offers an economical, easily transportable and storable
means of collecting peripheral blood samples for high
quality DNA and numerous other biomarkers [1-7]. As
compared to venipuncture, blood spot collection is more
convenient (i.e. can be done by oneself at home), and
while this method is invasive, it may be considered less so
among participants. In the U.S. Radiologic Technologists
(USRT) study, we have routinely collected venipuncture
blood samples, but cost concerns as well as moderate
response proportions prompted an evaluation of alterna-
tive methods for collecting peripheral blood samples.
To determine if offering blood spot collection would
increase participation in genetic epidemiologic studies,
we conducted a study of collecting dried blood spot cards
by mail among 390 female USRT cohort participants
selected for a nested case-control study of breast cancer
who declined to provide a venipuncture blood sample.
We also assessed the impact of an incentive to encourage
participation by randomizing participants to receive
either a $2.00 bill or no incentive with the blood spot col-
lection kits.
Methods
This study was approved by the human subjects review
boards of the National Cancer Institute and the University
of Minnesota.
Study population
Study participants were women that were selected from
eligible cases and controls identified as part of a genetic
case-control study of breast cancer (between 1999 and
2003) nested in the USRT cohort [8] who had declined to
provide a venipuncture blood sample. Of 1402 eligible
breast cancer cases, 871 (62%) agreed to participate in the
original study. One-hundred and fifty-five cases could not
be located or were unable to participate, and 376 refused
to participate, of which 343 specifically declined to pro-
vide a venipuncture blood sample. Of the 2,268 breast
cancer controls that were identified, 1093 (48%) agreed to
participate in the genetics study. Three-hundred and
thirty-six controls could not be located or were unable to
participate; 839 controls refused to participate in the
study of which 814 specifically declined to provide a ven-
ipuncture blood sample.
Of the 343 cases and 814 controls, subjects were excluded
from the blood spot study if they began working before
1950 (n = 171), did not complete the most recent cohort
survey (n = 349), gave blood for an earlier genetic study (n
= 9), previously refused any DNA collection (n = 31), were
deceased (n = 55), too ill or unable to participate (n = 6),
taking blood thinners (n = 5) or had withdrawn from fur-
ther study participation (n = 29). During 2006, all remain-
ing cases (n = 134) and a random sample of controls (n =
256) were recruited. The time between refusal to provide
a venipuncture sample and recruitment for blood spot
collection ranged from 2 to 9 years (mean = 4.4). Within
case and control groups, subjects were randomized for
contact order and then for receipt of a $2.00 bill incentive
with the blood spot collection kit. Each technologist was
sent an advance letter by the US postal system, followed
one week later by a blood spot collection kit, with up to 3
follow-up mailings or telephone calls for non-responders
approximately every 3 weeks. Sixty-seven cases and 129
controls received no incentive, and 67 cases and 127 con-
trols received the incentive. Demographic variables for
these subjects were obtained from previously adminis-
tered questionnaires [9]; reconstruction of occupational
ionizing radiation breast doses and personal diagnostic
ionizing radiation exposures has been described previ-
ously [8].
Dried blood spot kit
Each subject was mailed a self-collection kit that con-
tained a dried blood spot collection card (Whatman Pro-
tein Saver Card for five 75-80 μL blood samples), a BD
Genie™ lancet (2.0 mm depth, 1.5 mm width), alcohol
wipe, gauze pad, adhesive bandage, desiccant pouch, and
a foil bag for the completed blood spot card. A consent
form, detailed instructions for self-collection of a finger
stick capillary dried blood spot sample and a question-
naire to collect updated breast cancer risk factor informa-
tion were included with the kit, along with an envelope
and first class mailing stamp for the subjects to return the
specimens.
Statistical analysis
We used contingency table and logistic regression analy-
ses (SAS Institute, Cary, North Carolina, Release 8.02) to
examine participation in the dried blood spot collection
according to incentive, time between initial refusal and
the request for dried blood spots, radiation exposure and
demographic characteristics including year of birth, mari-
tal status, smoking status and region of residence. We alsoBMC Medical Research Methodology 2009, 9:76 http://www.biomedcentral.com/1471-2288/9/76
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used t-tests to compare log-transformed occupational
breast radiation dose and personal diagnostic radiation
breast exposure scores between participants and non-par-
ticipants. Analyses were stratified by case-control status.
To assess whether the incentive and other characteristics
differentially affected participation among cases and con-
trols, we added cross products terms to logistic regression
models that adjusted for the main effect of case-control
status and the variable under consideration. Because 95%
of our subjects were non-Hispanic Caucasian, we did not
examine associations with race/ethnicity; however, the
results did not differ when we restricted analyses to non-
Hispanic Caucasian subjects. Mutual adjustment for the
variables evaluated in this study had minimal impact on
the point estimates of interest (< 10%) in our logistic
regression models, so we present univariate results only,
except for the radiation exposure variables, for which the
analyses were adjusted for year of birth because of the
potential confounding effects of age; the greater the age,
the more opportunity to be exposed to occupational and
personal diagnostic radiation. All statistical tests were
two-sided and statistical significance was assessed at p ≤
0.05.
Results
Of 390 cases and controls in the USRT breast cancer
genetic study who previously declined to provide a veni-
puncture blood sample, 121 (31%) provided a dried
blood spot card. A greater proportion of cases participated
in the blood spot collection than controls (37% versus
28%) (p = 0.07).
Cases who received the $2.00 bill were more likely to pro-
vide a dried blood spot card than were cases who received
no incentive (48% versus 27%; OR = 2.5; 95% CI: 1.2-5.1;
p = 0.01) (Table 1); however we found little difference in
control participation according to incentive (29% for the
$2.00 bill versus 26% for no incentive; OR = 1.1; 9.5% CI:
0.7-2.0; p = 0.6). The test for a differential effect of incen-
tive on participation between cases and controls resulted
in a p-value of 0.09. On average, a greater number of years
passed between collection efforts for cases (mean = 5.5
years) than for controls (mean = 3.7 years). There was
some indication in Table 1 that cases were more likely and
controls were less likely to participate as a greater number
of years passed between collection efforts. These results,
however, were based on small numbers in the extreme cat-
egories and were not statistically significant. Furthermore,
controlling for years between collection efforts in logistic
regression models assessing the impact of incentive had
little impact on the point estimates.
After controlling for year of birth, we also observed a bor-
derline significant difference in the distribution of occu-
pational radiation breast dose among controls who did
and did not provide a dried blood spot card, with a greater
proportion of participating compared to non-participat-
ing controls being in the highest radiation dose category
(> 0.06 Gy) (Table 1). However, there was no significant
difference between the means of the log-transformed
occupational radiation breast doses among control partic-
ipants (mean = 0.02 Gy) and non-participants (mean =
0.03 Gy) (p = 0.5). We observed no significant differences
in participation among cases and controls according to
the other variables listed in Table 1, but there was a ten-
dency for younger individuals among cases and controls
and former and current smokers among cases to be less
likely to participate
Discussion
This study demonstrates that collection of dried blood
spot cards in addition to venipuncture blood samples may
be a feasible method to increase overall participation in
genetic case-control studies. Among randomly selected
women who previously declined to provide a venipunc-
ture blood sample for a breast cancer case-control study
[8], dried blood spot cards were successfully collected
from 37% of cases and 28% of controls. For the underly-
ing breast cancer case-control study [8], assuming that no
incentive was offered and applying a conservative
response estimate of 25%, we estimate that collection of
dried blood spots after an initial attempt to collect veni-
puncture blood samples would increase the overall partic-
ipation among cases from 62% to 68% and among
controls from 48% to 57%.
Convenience of blood spot collection over venipuncture
blood draw is the most likely reason for the increase in
participation. Subjects were able to perform the procedure
at home and return the blood spot card through regular
mail. In comparison, venipuncture necessitated schedul-
ing appointments at laboratories or clinics and then
arranging to have the blood samples picked up by a cou-
rier service. In general, the collection of capillary blood by
finger stick is considered to be less invasive than blood
draw using venipuncture because there is lower risk of soft
tissue injury. However, there may have been discomfort
and difficulties in applying the finger stick procedure
among study subjects, so we can only speculate as to
whether relative invasiveness was a factor in increased par-
ticipation.
Our results suggest a differential effect of the $2.00 incen-
tive between cases and controls, with cases responding
more favorably to the incentive. We compared demo-
graphic characteristics between cases and controls and did
not find any significant differences to explain the
increased response among cases. A differential response
proportion among cases and controls raises the concern of
potential response bias, although we did not find any sig-BMC Medical Research Methodology 2009, 9:76 http://www.biomedcentral.com/1471-2288/9/76
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nificant differences when comparing characteristics
between the cases who responded to the $2.00 bill and
the cases who did not.
We also observed a significant difference in the distribu-
tion of occupational radiation breast doses between con-
trols who provided a blood spot card and controls who
did not. It appeared that a greater proportion of controls
with higher doses chose to participate, however, this find-
ing was based on a small number of technologists in the
highest dose category, and the difference in the log trans-
formed mean occupational ionizing radiation breast
doses between the participating and non-participating
controls was not significant.
The use of financial incentives to improve response to
questionnaires has been previously investigated in the
USRT cohort [10]; the response proportion for the $2.00
bill among persistent non-responders to a questionnaire
survey was similar to the response proportion we
observed among controls receiving the $2.00 bill in the
present study (29%). Coogan et al examined the effect of
financial incentives on case and control participation in a
telephone interview for a study of colorectal cancer [11].
They found that cases randomized to receive $5.00 were
slightly less likely to participate than cases that were not
offered the incentive (64% and 68%, respectively). How-
ever, participation among controls offered a $5.00 incen-
tive was significantly higher than among controls
approached for participation in the previous year without
an incentive (56 and 44% respectively, p < 0.001). Gilbart
Table 1: Dried blood spot collection among breast cancer cases and control who initially declined to provide a venipuncture blood sample, 
according to incentive, demographic characteristics and selected cancer risk factors
Cases (n = 134) Controls (n = 256)
No blood spot Blood spot OR (95% CI) p-valuea No blood spot Blood spot OR (95% CI) p-valuea
Incentive Group
No incentive 49 (73%) 18 (27%) ref 0.01 95 (74%) 34 (26%) ref 0.6
$2 incentive 35 (52%) 32 (48%) 2.5b(1.2,5.1) 90 (71%) 37 (29%) 1.1 (0.7,2.0)
Year of birth
< 1935 18 (56%) 14 (44%) ref 0.8 32 (63%) 19 (37%) ref 0.4
1935 to 1944 35 (63%) 21 (38%) 0.8 (0.3,1.9) 90 (75%) 30 (25%) 0.6 (0.3,1.1)
1945 to 1954 24 (67%) 12 (33%) 0.6 (0.2,1.7) 53 (29%) 19 (26%) 0.6 (0.3,1.3)
≥ 1955 7 (70%) 3 (30%) 0.6 (0.1,2.5) 10 (77%) 3 (23%) 0.5 (0.1,2.0)
Marital Status
Married/Living Together 53 (61%) 34 (39%) ref 0.8 135 (73%) 50 (27%) ref 0.9
Widowed/
Divorced/
Seperated
23 (66%) 12 (34%) 1.1 (0.6,2.2) 38 (70%) 16 (30%) 1.1 (0.6,2.2)
Never Married 8 (67%) 4 (33%) 1.1 (0.4,3.4) 12 (71%) 5 (29%) 1.1 (0.4,3.3)
Smoking Status
Never 39 (56%) 31 (44%) ref 0.2 99 (71%) 40 (29%) ref 0.8
Former 36 (71%) 15 (29%) 0.5 (0.2,1.1) 60 (75%) 20 (25%) 0.8 (0.4,1.5)
Current 9 (69%) 4 (31%) 0.6 (0.6,2.0) 26 (72%) 10 (28%) 1.0 (0.4,2.2)
Unknown 0 (0%) 0 (0%) N/A 0 (0%) 1(100%) N/A
Region of residencec
Northeast 16 (57%) 12 (43%) ref 0.7 29 (67%) 14 (33%) ref 0.9
Midwest 19 (63%) 11 (37%) 0.8 (0.3,2.2) 48 (73%) 18 (27%) 0.8 (0.3,1.8)
South 15 (54%) 13 (46%) 1.2 (0.4,3.3) 37 (69%) 17 (31%) 1.0 (0.4,2.2)
West 11 (61%) 7 (39%) 0.8 (0.2,2.7) 24 (69%) 11 (31%) 0.9 (0.4,2.5)
Unknown 23 (77%) 7 (23%) 0.4 (0.1,1.2) 47 (81%) 11 (19%) 0.5 (0.2,1.2)
Occupational radiation breast dose (Gy)
0 to 0.02 56 (65%) 30 (35%) ref 0.9 124 (72%) 49 (28%) ref 0.02
> 0.02 to 0.04 13 (59%) 9 (41%) 1.2 (0.5,3.4) 34 (89%) 4 (11%) 0.3 (0.1,0.9)
> 0.04 to 0.06 6 (60%) 4 (40%) 1.2 (0.3,4.8) 10 (71%) 4 (29%) 1.0 (0.3,3.4)
> 0.06 9 (56%) 7 (44%) 1.5 (0.5,4.3) 17 (55%) 14 (45%) 2.1 (0.9,4.6)
Personal diagnostic radiation breast dose score
0 to 0.02 47 (67%) 23 (33%) 0.5 121 (73%) 44 (27%) 0.9
> 0.02 to 0.04 12 (50%) 12 (50%) 2.0 (0.8,5.2) 33 (70%) 14 (30%) 1.2 (0.6,2.4)
> 0.04 to 0.06 9 (60%) 6 (40%) 1.4 (0.4,4.3) 14 (74%) 5 (26%) 1.0 (0.3,2.9)
> 0.06 16 (64%) 9 (36%) 1.1 (0.4,3.0) 17 (68%) 8 (32%) 1.3 (0.5,3.2)
aChi-square test excluded Unknown category
bp-value for super-multiplicative effect modification = 0.09
cU.S. Census Bureau definition: Northeast = CT, ME, MA, NH, RI, VT, NJ, NY, PA, DE, DC, MD; Midwest = IL, IN, MI, OH, WI, IA, KS, MN, MO, NE, ND, 
SD; South = FL, GA, NC, SC, VA, WV, AL, KY, MS, TN, AR, LA, OK, TX; West = AZ, CO, ID, MT, NV, NM, UT, WY, AK, CA, HI, OR, WABMC Medical Research Methodology 2009, 9:76 http://www.biomedcentral.com/1471-2288/9/76
Page 5 of 6
(page number not for citation purposes)
et al and Parkes et al found that $5.00 incentives increased
responses to questionnaires among controls from cancer
case-control studies by 20 and 15%, respectively [12,13];
Parkes et al [8] also found that a $2.00 bill increased par-
ticipation among controls by 11%. The focus of previous
incentive studies was questionnaire response, so strict
comparison of response to blood collection in the present
study is difficult.
Strengths of the present study include the examination of
incentives among both cases and controls and the ability
to examine the effect of a variety of factors on participa-
tion, including primary exposure variables which are una-
vailable for non-responders in many studies. We did not
observe any significant differences among characteristics
that we evaluated; however some comparisons may have
had limited power because of small numbers of technolo-
gists in the comparison groups.
In this study, two to nine years passed between the collec-
tion efforts. It is possible that blood spot recruitment fol-
lowing more immediately after requesting a venipuncture
sample or offered in lieu of a venipuncture sample may
have affected our response proportions. Nonetheless, the
length of this time period was not a significant predictor
of participation and adjustment for the time between col-
lection efforts had a minimal effect on our results.
The applicability of our results to other populations, par-
ticularly men, is another limitation of this study given that
participants were women that worked as medical profes-
sionals and were predominantly non-Hispanic. Further-
more, we were unable to assess the quantity or quality of
the genetic material obtained from the blood spot cards
collected for this study; however, it has been previously
demonstrated that blood spots are a stable source of high
quality DNA [1] that can be effectively used to conduct
genome-wide association studies [3].
Conclusion
While the generalizability of our findings are limited due
to the focus on female radiologic technologists and the
time period between biospecimen collection efforts, our
study does demonstrate that dried blood spots may be a
feasible method for increasing participation in genetic
studies. Other genetic or biomarker studies may choose to
consider collecting dried blood spot cards from study sub-
jects given their convenience, ease of transport and stor-
age, versatility and lack of demonstrable bias by case-
control status or incentive.
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